| Dr Anthony Pontarelli, DPM | |
|
1098 W Baltimore Pike, Ste 3305, Media, PA 19063-5139 | |
| (610) 566-5236 | |
| (610) 891-7135 |
| Full Name | Dr Anthony Pontarelli |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 42 Years |
| Location | 1098 W Baltimore Pike, Media, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730148206 | NPI | - | NPPES |
| 0932513 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | SC002483L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riddle Memorial Hospital | Media, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Del Val Foot And Ankle Pc | 2769587351 | 2 |
News Archive
A study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a new immunohistochemical test is reliable in diagnosing a dangerous arrhythmic heart disease known as arrhythmogenic right ventricular cardiomyopathy (ARVC).
Scientific research published in the current issue of the Journal of the American Medical Informatics Association (JAMIA) reports on a study of genetic variants that influence human susceptibility to peripheral arterial disease (PAD), made possible by leveraging electronic medical records (EMRs; also called EHRs or electronic health records).
Men who undergo prostate-cancer screening should discuss with a doctor the uncertainties, risks and benefits of the test before it is performed, says Edward Partridge, M.D., president-elect of the American Cancer Society National Board of Directors and director of the University of Alabama at Birmingham Comprehensive Cancer Center.
For patients age 40 and over with chronic obstructive pulmonary disease (COPD), hospital readmissions within 30 days of initial treatment were 30 percent higher among blacks than Hispanics or Asians and Pacific Islanders and about 9 percent higher than whites in 2008, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Dynex Technologies announced today it has received approval from China's State Food and Drug Administration (SFDA) to market the DS2 automated enzyme-linked immunosorbent assay (ELISA) analyzer in China.
› Verified 6 days ago
| Provider Name | Del Val Foot & Ankle Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1487613311 PECOS PAC ID: 2769587351 Enrollment ID: O20070410000162 |
News Archive
A study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a new immunohistochemical test is reliable in diagnosing a dangerous arrhythmic heart disease known as arrhythmogenic right ventricular cardiomyopathy (ARVC).
Scientific research published in the current issue of the Journal of the American Medical Informatics Association (JAMIA) reports on a study of genetic variants that influence human susceptibility to peripheral arterial disease (PAD), made possible by leveraging electronic medical records (EMRs; also called EHRs or electronic health records).
Men who undergo prostate-cancer screening should discuss with a doctor the uncertainties, risks and benefits of the test before it is performed, says Edward Partridge, M.D., president-elect of the American Cancer Society National Board of Directors and director of the University of Alabama at Birmingham Comprehensive Cancer Center.
For patients age 40 and over with chronic obstructive pulmonary disease (COPD), hospital readmissions within 30 days of initial treatment were 30 percent higher among blacks than Hispanics or Asians and Pacific Islanders and about 9 percent higher than whites in 2008, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Dynex Technologies announced today it has received approval from China's State Food and Drug Administration (SFDA) to market the DS2 automated enzyme-linked immunosorbent assay (ELISA) analyzer in China.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anthony Pontarelli, DPM 1098 W Baltimore Pike, Ste 3305, Media, PA 19063-5139 Ph: (610) 566-5236 | Dr Anthony Pontarelli, DPM 1098 W Baltimore Pike, Ste 3305, Media, PA 19063-5139 Ph: (610) 566-5236 |
News Archive
A study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a new immunohistochemical test is reliable in diagnosing a dangerous arrhythmic heart disease known as arrhythmogenic right ventricular cardiomyopathy (ARVC).
Scientific research published in the current issue of the Journal of the American Medical Informatics Association (JAMIA) reports on a study of genetic variants that influence human susceptibility to peripheral arterial disease (PAD), made possible by leveraging electronic medical records (EMRs; also called EHRs or electronic health records).
Men who undergo prostate-cancer screening should discuss with a doctor the uncertainties, risks and benefits of the test before it is performed, says Edward Partridge, M.D., president-elect of the American Cancer Society National Board of Directors and director of the University of Alabama at Birmingham Comprehensive Cancer Center.
For patients age 40 and over with chronic obstructive pulmonary disease (COPD), hospital readmissions within 30 days of initial treatment were 30 percent higher among blacks than Hispanics or Asians and Pacific Islanders and about 9 percent higher than whites in 2008, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Dynex Technologies announced today it has received approval from China's State Food and Drug Administration (SFDA) to market the DS2 automated enzyme-linked immunosorbent assay (ELISA) analyzer in China.
› Verified 6 days ago
Dr. Todd Rice, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 101 N Monroe St, Media, PA 19063 Phone: 610-595-3668 Fax: 610-565-9722 | |
Dr. John A Pron, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1118 W Baltimore Pike Ste 100, Media, PA 19063 Phone: 484-227-8370 Fax: 484-227-1645 | |
David C Erfle, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 101 N Monroe St, Media, PA 19063 Phone: 610-565-3668 Fax: 610-565-9722 | |
Colin P Flannery, D.P.M Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 101 N Monroe St, Media, PA 19063 Phone: 610-565-3668 Fax: 610-565-9722 | |
Healthmark Foot And Ankle Associates, P.c. Podiatrist Medicare: Medicare Enrolled Practice Location: 101 N Monroe St, Media, PA 19063 Phone: 610-565-3668 Fax: 610-565-9722 | |
Sutera & Jones Surgical Podiatry, P.c. Podiatrist Medicare: Medicare Enrolled Practice Location: 280 N Providence Rd, Upper Level, Media, PA 19063 Phone: 610-566-4383 Fax: 610-566-1856 | |
Dr. Angelo B Sutera Jr., DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 280 N Providence Rd Ste 103, Media, PA 19063 Phone: 610-566-4563 Fax: 610-566-1856 |